Can the size and duration of clinical trials in new drug applications predict post-approval safety warnings?

Jeremy Clark, Andrea Menclova

Year of publication:	[2025]
Authors:	Clark, Jeremy ; Menclova, Andrea Kutinova
Publisher:	Christchurch, New Zealand : Department of Economics and Finance, UC Business School, University of Canterbury
Subject:	Clinical trials \| Sample size \| Duration \| New drug applications \| Drug approvals \| Safety warnings \| Arzneimittel \| Pharmaceuticals \| Pharmakologie \| Pharmacology \| Dauer \| Pharmaindustrie \| Pharmaceutical industry \| Schätzung \| Estimation \| Arzneimittelrecht \| Pharmaceutical law

freely available

Full text |

More access options

econpapers.repec.org

Check Google Scholar

In German libraries (KVK)

Which error do you want to report?

Report: URL of this record is broken

Please note: Sometimes more than one URL is available for a resource. Please click on "More Options" to display these URLs

Report: Addition of an URL to that resource

Please note: Sometimes more than one URL is available for a resource. Please click on "More Options" to display these URLs

Report: The language(s) of that resource is/are…

Please note: Required language not in the list? Please use comment field

Report: Addition of an identifier to that resource

Report: report typo

Report: Add statement

Report: Add keywords

Please use the commentary box to describe other errors

Would you like to receive a feedback?

Commentary

Please type the code from the image

For general questions please use this address.

Persistent link: https://www.econbiz.de/10015394355

A service of the